Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery

Abroad (travel likely)RecruitingPHASE2

Conditions

Intrahepatic Bile Duct Cancer · Intrahepatic Cholangiocarcinoma (Icc) · Intrahepatic Bile Duct Carcinoma · Intrahepatic Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Erasmus Medical Center, Rotterdam, South Holland, Netherlands
Contact: Study coordinator (Bas Groot Koerkamp, MD, PhD) · b.grootkoerkamp@erasmusmc.nl · +31(0)107031810
Contact: Study coordinator (Thomas C Zwaan, MD) · t.zwaan@erasmusmc.nl · +31(0)621218051
Contact: Principal Investigator (Bas Groot Koerkamp, MD, PhD)

Study leads

Bas Groot Koerkamp, MD, PhD
Principal Investigator
Erasmus Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Bile Duct Cancer · Cholangiocarcinoma · Cholangiocarcinoma Non-resectable

Abroad (travel likely)RecruitingPHASE2

Boston, United States

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Fairfax, United States

A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (Icc)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shanghai, China

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States